Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1577494 | 0.86 | ALDH1A1 (0.30) | — | |
| SCHEMBL1577864 | 0.86 | ALDH1A1 (0.30) | — | |
| SCHEMBL9618786 | 0.86 | — | — | |
| SCHEMBL9118174 | 0.86 | ALDH1A1 (0.30) | — | |
| SCHEMBL1577957 | 0.86 | ALDH1A1 (0.30) | — | |
| SCHEMBL25338226 | 0.86 | — | — | |
| Lithium Ion SCHEMBL380890 | 0.86 | — | — | |
| Potassium Ion SCHEMBL56363 | 0.86 | — | — | |
| SCHEMBL21357941 | 0.86 | — | — | |
| SCHEMBL5445634 | 0.86 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 893 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090336-A1 | PROCESSES FOR PREPARING KRAS INHIBITORS | INCYTE CORPORATION (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4720050-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4683926-A1 | MONO-SUBSTITUTED TIN COMPOUNDS AND RELATED METHODS | Entegris, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250372660-A1 | HIGH-ENERGY LITHIUM METAL BATTERIES ACHIEVED BY INORGANIC AND ORGANIC COATINGS | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2025-12-04 | — | — | US | claimed |
| WO-2025080589-A1 | PROCESSES FOR PREPARING KRAS INHIBITORS | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | claimed |
| WO-2025042679-A1 | FASTER AUTOMATED ITERATIVE C-C BOND FORMATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-02-27 | — | — | WO | claimed |
| WO-2024249672-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| WO-2024227071-A1 | SYNTHESIS OF DURLOBACTAM | ENTASIS THERAPEUTICS LIMITED (GB) | 2024-10-31 | — | — | WO | claimed |
| US-20240317781-A1 | MONO-SUBSTITUTED TIN COMPOUNDS AND RELATED METHODS | ENTEGRIS, INC. | 2024-09-26 | — | — | US | claimed |
| WO-2024197115-A1 | MONO-SUBSTITUTED TIN COMPOUNDS AND RELATED METHODS | ENTEGRIS, INC. (US) | 2024-09-26 | — | — | WO | claimed |
| EP-0575463-A1 | C-TERMINAL PEPTIDE SEQUENCING USING DIPHENYL PHOSPHOROISOTHIOCYANATIDATE AND PYRIDINE | CITY OF HOPE (US) | 1993-12-29 | — | — | EP | claimed |
| WO-1993011436-A1 | C-TERMINAL PEPTIDE SEQUENCING USING DIPHENYL PHOSPHOROISOTHIOCYANATIDATE AND PYRIDINE | CITY OF HOPE (US) | 1993-06-10 | — | — | WO | claimed |
| US-5180807-A | C-terminal peptide or protein sequencing reagent and method | CITY OF HOPE (US) | 1993-01-19 | — | — | US | claimed |
| EP-0483162-A4 | SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS | — | 1993-01-07 | — | — | EP | claimed |
| EP-0483162-A1 | SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS. | HOPE CITY (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991018008-A1 | SEQUENTIAL C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS | CITY OF HOPE (US) | 1991-11-28 | — | — | WO | claimed |
| US-5059540-A | Coupling the peptide with a silane isothiocyanate to form a thiohydantoin derivative | CITY OF HOPE (US) | 1991-10-22 | — | — | US | claimed |
| EP-0200307-B1 | IMPROVED PROCESS FOR PRODUCTION OF QUINOLINE-3-CARBOXYLIC ACID ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY (US) | 1989-12-20 | — | — | EP | claimed |
| EP-0200307-A1 | Improved process for production of quinoline-3-carboxylic acid antibacterial agents | WARNER-LAMBERT COMPANY (US) | 1986-11-05 | — | — | EP | claimed |
| US-4003917-A | Siloxanediolate complexes and preparation thereof | GENERAL ELECTRIC COMPANY (US) | 1977-01-18 | — | — | US | claimed |